Ningbo Aucheer Biotechnology Co., Ltd
Aucheer is a high-tech biological enterprise focusing on the early detection, diagnosis, prevention and monitoring of diseases. By providing reliable, fast and convenient in vitro diagnostic products, it can provide accurate test results for diagnosis and treatment. At present, the company's biomedical team continues to conduct in-depth exploration and prospective research in the field of high-risk diseases for pregnant women such as hypertension. We will be committed to providing leading clinical diagnosis solutions for maternal and child health.
The Aucheer R&D team brings together global technical forces, integrates excellent talents at home and abroad, and builds a technology platform based on microfluidic technology, immunofluorescence, chemiluminescence, molecular diagnosis, and antibody raw material research and development, forming a technology platform around maternal and child health, cardiovascular, and diabetes A series of products developed in subjects such as, infection, kidney disease, and oncology. In the future, we will mainly use advanced technologies such as artificial intelligence and medical big data to add value to the current diagnostic platform to create value for medical institutions and patients.
Since its establishment in 2009, Aucheer has been adhering to a rigorous work attitude, with a professional academic innovation spirit, and accelerating the transformation of cutting-edge scientific research results. In 2017, the company was selected as "Ningbo's Most Valuable Investment Enterprise" and "Zhejiang High-growth Technology Enterprise". We have won many reputations with our strength, and always keep in mind the core values of "responsibility, integrity, thinking, quality, tenacity, and gratitude", and aspire to become a respected life technology company!